Last Updated: Tue, 03/24/2026
Syllabus
General Class Information
Academic year:
2026
Semester:
Spring
Course prefix:
BMED
Course number:
8813
Section:
FBC
CRN
92907
Instructor first name:
Adam
Instructor last name:
McCallum
Catalog Description

This course is designed to expose graduate-level biomedical engineering students at Georgia Tech and Emory University

to the fundamental concepts and processes involved in the commercialization of biomedical technologies. The course will

be heavily project-focused. At the beginning of the course, students will be asked to propose a technology/idea from a

current project in their dissertation research, previous research project, or research paper/patent; assess the commercial

potential of that technology; and carry it through every stage of the technology transfer and commercialization processes

that will be taught in the course, starting with simulating the submission of an invention disclosure and preparing parts of a

mock provisional patent application, all to help advance the technology from a research project to a potentially commercially

viable product. Throughout these steps, students will be continually refining the commercialization strategy of their

technology to ultimately assess whether the technology is better-suited for licensing or venturing. At the end of the course,

students will be asked to prepare and deliver a business-oriented pitch of their technology to the class to simulate pitching

to a panel of venture capitalists and other investors. Each of the topics and associated projects is intended to expose

students to real-world milestones that entrepreneurs and innovators encounter during the development of academic

technology innovations. Several lectures in this course will be delivered by both internal and external (with respect to

Georgia Tech/Emory) subject matter experts, who also serve as resources for innovators at Georgia Tech and Emory who

are interested and/or engaged in commercialization.

Administrative Data
Course status
Active